Key points are not available for this paper at this time.
In studies of serial cancer markers or disease states and their relation to survival, data on the marker or state are usually obtained at infrequent time points during follow-up. A Markov model is developed to assess the dependence of risk of death on marker level or disease state and inferences within this model are based directly on data collected in this haphazard way. An application relating changing levels of serum alpha-fetoprotein to death in hepatocellular carcinoma is discussed in detail.
A 1986 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: